Evidence map›Paper›PMID 23341921›Full record

ArticlePloS one2013

Amphitremida (poche, 1913) is a new major, ubiquitous labyrinthulomycete clade.

Fatma Gomaa, Edward A D Mitchell, Enrique Lara

Abstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Thraustochytrids: Evolution, Ultrastructure, Biotechnology, and Modeling.International journal of molecular sciences · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Checklist ofBiodiversity data journal · 2018
    Article
  9. Article
  10. How discordant morphological and molecular evolution among microorganisms can revise our notions of biodiversity on Earth.BioEssays : news and reviews in molecular, cellular and developmental biology · 2014
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fatma GomaaLaboratory of Soil Biology, University of Neuchâtel, Neuchâtel, Switzerland. fatma.gomaa@unine.ch
Edward A D Mitchell
Enrique Lara

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Micro-eukaryotic diversity is poorly documented at all taxonomic levels and the phylogenetic affiliation of many taxa - including many well-known and common organisms - remains unknown. Among these incertae sedis taxa are Archerella flavum (Loeblich and Tappan, 1961) and Amphitrema wrightianum (Archer, 1869) (Amphitremidae), two filose testate amoebae commonly found in Sphagnum peatlands. To clarify their phylogenetic position, we amplified and sequenced the SSU rRNA gene obtained from four independent DNA extractions of A. flavum and three independent DNA extractions of A. wrightianum. Our molecular data demonstrate that genera Archerella and Amphitrema form a fully supported deep-branching clade within the Labyrinthulomycetes (Stramenopiles), together with Diplophrys sp. (ATCC50360) and several environmental clones obtained from a wide range of environments. This newly described clade we named Amphitremida is diverse genetically, ecologically and physiologically. Our phylogenetic analysis suggests that osmotrophic species evolved most likely from phagotrophic ancestors and that the bothrosome, an organelle that produces cytoplasmic networks used for attachment to the substratum and to absorb nutrients from the environments, appeared lately in labyrithulomycete evolution.

Indexed as

PhylogenyAmoebaBase SequenceBayes TheoremGenes, rRNALikelihood FunctionsMolecular Sequence DataRibosome Subunits, Small

Identifiers

PMID23341921
PMCPMC3544814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.